Bart Pardon • UGent Calf Health; Clinic for Ruminants • Department of Internal Medicine, Reproduction and Population Medicine, Faculty of Veterinary Medicine, Ghent University
Abstract
Bovine respiratory disease
(BRD) remains a major challenge for the cattle industry, particularly in the
context of increasing demands for reduced antimicrobial use, improved animal
welfare and sustainable production. At the same time, respiratory diagnostics
are evolving rapidly, offering veterinarians an expanding range of tools. This
article provides an overview of current and emerging diagnostic approaches for
BRD and aims to help veterinarians select and apply them in a targeted and
cost-effective manner. A stepwise diagnostic approach is proposed, combining
early disease detection, lung ultrasonography, appropriate respiratory tract
sampling and laboratory diagnostics. Sampling techniques and their indications
are discussed, together with established and emerging laboratory methods,
including bacterial culture, multiplex PCR, MALDI-TOF, nanopore sequencing and
rapid point-of-care testing. Strategic pooling of samples can further improve
cost-effectiveness at herd level. Rather than searching for a single optimal
diagnostic test, test selection should be adapted to the clinical question,
pathogen and herd context. Ultimately, diagnostic tests only provide data;
their value and return on investment depend on the veterinarian’s ability to
translate these data into targeted treatment, control and prevention measures.
Respiratory diagnostics for
cattle have never before been so extensive, accessible and affordable. At the
same time, the context in which we need to use them has never been so
demanding, with increasing challenges regarding antimicrobial use, animal welfare,
economics and sustainable production. The rapid increase in the number of
diagnostic tests, combined with a generally slower development of their correct
interpretation and on-farm application, may possibly overwhelm veterinarians.
The aim of this article is to provide an overview of diagnostic tests for
bovine respiratory disease (BRD), discuss possibilities and limitations and
come to some practical advice.
We live in interesting times,
with unprecedented digitalisation and technological advancement occurring at a
pace that is sometimes difficult to follow, but offering a glimpse of an
improved future. Despite this, bovine respiratory disease is still a million-dollar
challenge in the context of increasing consumer demands regarding antimicrobial
use, animal welfare, environmental concerns and pressure to produce at low
cost. Diagnostics are at the centre of the transition in BRD management that is
currently taking place, aiming to finally make the step, in a responsible way,
away from metaphylactic antimicrobial therapy towards individual therapy and a
preventative approach. This transition needs to ensure that no additional
production losses or animal welfare issues occur.
A few figures illustrate the
scale of the problem. In a prospective study of 3,519 white veal calves in
Belgium, 14.8% of calves were individually treated for BRD and pneumonia
accounted for 27.1% of deaths. Mortality increased from 4.3% in calves not treated
for BRD to 12.0% after one episode and 33.3% after three or more episodes,
while hot carcass weight decreased by 8.2 kg after one episode and by 41.6 kg
after three or more (Pardon et al., 2013). In dairy heifers, a meta-analysis
showed that calfhood BRD is associated with 2.85 times higher odds of
mortality, a 67 g/d lower average daily gain and 121 kg less milk in first
lactation (Buczinski et al., 2021). Lung lesions detected by ultrasound also
have a lasting impact: among 215 Holstein heifers followed during their first
eight weeks of life, those with at least one episode of lung consolidation
produced approximately 525 kg less milk over 305 days in first lactation (Dunn
et al., 2018). In France, the association between pathogens and ultrasonographic
lung lesions has also been described in young fattening bulls, highlighting in
particular the role of bovine coronavirus (Rouault et al., 2024). Late
identification weighs on these outcomes: in a large cohort of Californian dairy
calves, 35 of the 52 calves that died from BRD had received only one treatment
protocol, suggesting that disease was not identified early enough for treatment
to be effective (Dubrovsky et al., 2020). Moreover, without identification of
the primary pathogen involved, control measures remain generic rather than
targeted.
Based on its research, UGent Calf
Health proposes a step-by-step approach to BRD problems, which starts with an
early warning, followed by lung ultrasonography (LUS) to map the problem and
potentially already intervene medically. The third step is crucial, as it
involves respiratory tract sampling and aetiological diagnostics. The final
step uses information from laboratory diagnostics to tailor a pathogen-oriented
approach, which, in a broad framework, differentiates herds with viral
infections from Mycoplasma bovis herds and from herds in which only
opportunistic infections (Pasteurellaceae) are found. The difference
with the classic, so-called one-size-fits-all recommendations, mostly in the
form of checklists or broad vaccination, is that based on the pathogen detected
critical control points are identified and modified, thereby focusing farm
resources where they may have the greatest return.
The trends in diagnostics in
cattle medicine are clear and, like human medicine, point towards multiplex PCR
panels, sequencing-based methods and rapid point-of-care testing. Adoption may
be slower and unequally distributed due to costs, infrastructure, access to
infrastructure and a lack of species-specific validation. This article aims to
provide an overview of current and emerging diagnostic tools for BRD and to
help veterinarians navigate rapid technological advances, enabling them to
select and apply diagnostics in a targeted and cost-effective manner.
Undoubtedly, over the last decade
on farm thoracic ultrasound has become one of the most significant improvements
in BRD management, with a high absorption capacity, meaning that it has
potential to be applied across all types of cattle farming. It is consistently
reported as the best diagnostic test, clearly outperforming clinical signs,
especially when animals are assessed at a single time point (Lowie et al.,
2022) (Buczinski et al., 2026). However, the fact that we do not yet see it
appropriately applied on all farms, means that there are drawbacks. A major
drawback is practical application, namely the need for a reliable scan
technique that takes little time. The hurdles in training and the importance of
certification have become clear, and with the UGent spin off company qTUS (www.qtus-vet.com)
offering high-quality blended training sessions and certifying veterinarians
for lung scanning, there is nothing besides willingness holding veterinarians
back from applying it in the field. Classification tools such as the qTUS score
help differentiate pneumonia cases, better estimate prognosis and even
individualise antimicrobial therapy length duration, overall reducing
antimicrobial use (Jourquin et al., 2025). However, with more users, more
practical questions arise, especially regarding the timing of LUS. Strategic
scanning moments, such as grouping or arrival, have been identified and
successfully applied on farm. The ideal situation would actually be the
integration of continuous sensor monitoring of behaviour, temperature or
coughing, generating early warnings and providing lists of attention calves to
the veterinarian performing the scans. This would ensure timely veterinary
intervention. This is however still work in progress.
Another clear reality that has
emerged both from research and from cases shared among qTUS users is that the
outcome of antimicrobial or anti-inflammatory therapy differs depending on both
the pathogen involved and host immunity (Jourquin et al., 2022, Jourquin et
al., 2024, Motus et al., 2026). This is generally framed as ‘context matters’,
and the message is that what happens at lung level and is seen with ultrasound
can only be fully understood or predicted by using laboratory diagnostics to
identify the pathogen(s) involved. This is why diagnostics are at the hub of
both identifying cases suitable for therapy and developing tailor-made control
and prevention measures.
There are different ways to
sample the respiratory tract in cattle, all with their pros and cons. Among
these, the deep nasopharyngeal swab (DNS), transtracheal wash and
non-endoscopic bronchoalveolar lavage (nBAL) are most frequently used (Pardon
and Buczinski, 2020). Whereas DNS has advantages in terms of cost, procedural
difficulty and animal friendliness, its use is mainly limited to identifying
primary pathogens, in casu viruses and Mycoplasma bovis. An important
point of attention is that the swab needs to be long enough to cover the
distance from the nares to the medial canthus of the eye to sample the ciliated
respiratory epithelium. There are interpretative issues when using DNS to
investigate opportunistic bacterial infections (Pardon and Buczinski, 2020).
For the latter purpose, a sample from the lower airways is needed. A
transtracheal wash avoids potential contamination during passage through the
nasal cavity but is limited to sampling around the tracheal bifurcation. This
may represent the lung, but only if the mucociliary system is not impaired,
which is often the case in pneumonia. In addition, there may be continuous
aspiration of tracheopharyngeal opportunists.
The nBAL procedure is somewhat
shorter and can be performed in an unsedated animal using commercial or
custom-made catheters (eg. UGent nBAL catheter with outer diameter of 4mm and
inner diameter of 2mm). The author likes to call it an ‘80/80% technique’,
meaning that in approximately 80% of calves, the procedure results in an
interpretable culture, being either a pure culture, dominant culture or
negative culture. The other 20% are polymicrobial samples, which has been
associated with a sampler effect (Van Driessche et al., 2017). So, here too,
adequate training is key.
An overview, with advantages,
disadvantages and future prospects for diagnostics for respiratory tract
infections is given in table 1. For decades, analysis of respiratory samples
was limited to bacterial culture, mainly targeting Pasteurellaceae.
Bacterial culture will remain necessary, especially for antimicrobial
susceptibility testing, and typically takes about three days. Interpretation is
not always straightforward, certainly with opportunists, but at least there is
no discussion about viability. For M. bovis, conventional culture on
PPLO agar is limited both in terms of time (a minimum of six days of incubation
is needed) and sensitivity (Pardon and Buczinski, 2020). From the mid-2010s
onwards, PCR became more widely available to practitioners, offering the
advantage of testing for multiple pathogens at once, including viruses, with
high sensitivity. However, interpretation of the detection of opportunistic
pathogens is not straightforward, nor is estimating the infectious nature of
the pathogen. In theory, PCR can be performed within a day, but in practice a
turnaround time of three days is more common. Multiplex PCR is most commonly
used, whereas the added value of quantitative PCR requires further research.
Next in the line of innovation
was MALDI-TOF. The method identifies bacteria from cultures based on their
protein fingerprint and has become standard in laboratories. MALDI-TOF can also
be performed directly on samples or after a short incubation in enriched media.
For M. bovis, a rapid method was developed, providing sensitivity and
specificity both above 93.0%. The method is freely accessible and already
offered by laboratories in several EU countries (Bokma et al., 2020, Bokma et
al., 2021). The hallmarks of MALDI-TOF are speed and competitive pricing, with
bacterial identification possible within hours after culture for Pasteurellaceae
and in less than three days for M. bovis (Van Driessche et al., 2019)
(Bokma et al., 2020). A rapid antibiogram has also been achieved using a
MALDI-TOF method, named MBT-ASTRA, for oxytetracycline susceptibility in Pasteurella
multocida in cattle, with near-perfect accuracy compared with microdilution
(Van Driessche et al., 2018). Both direct detection and the possibility of
obtaining an antibiogram make us dream of obtaining bacterial identification
and an antibiogram within a single day. To the author's knowledge, the
combination of both methods has not yet found its way into routine laboratories
but is surely a future prospect.
The third innovation brought into
practice over the last five years is nanopore sequencing (Oxford Nanopore
Technologies). The method screens samples for the presence of DNA/RNA and
thereby identifies the pathogens present. The major advantage is that the
investigator no longer needs to specify which pathogens to test for. The method
has been validated and is commercially available for respiratory viruses and Mycoplasma
spp (Bokma et al., 2021). Sequencing also offers the possibility of strain
typing, which may provide insights into biosecurity breaches or the expected
efficacy of a vaccine against the circulating strain.
Despite not being a new
laboratory test, the more frequent use of Bayesian statistics to evaluate
diagnostic tests in cattle is a revolution. This method does not require a
gold-standard reference test, resulting in more reliable estimates of
sensitivity and specificity. For example, a study comparing PCR, nanopore
sequencing and rapid MALDI-TOF for M. bovis detection in nBAL samples
showed PCR to be sensitive but not always specific (cross-positivity),
sequencing to be very specific but less sensitive, and MALDI-TOF to provide a
more balanced combination of sensitivity and specificity (Bokma et al., 2021).
Whereas individual testing can be
costly and provide only limited additional information at herd level, testing
pooled samples (3–5 samples) may increase the likelihood of detecting the
pathogens involved without losing sensitivity and specificity compared with
individual testing (Bokma et al., 2021). To estimate where this evolution will
take us next, we can learn from ongoing developments in human medicine towards
broad multiplex (digital) PCR panels (syndromic panels; 15–25+ respiratory
viruses and bacteria), sequencing-based methods—both targeted sequencing for a
defined list of pathogens and metagenomic, hypothesis-free shotgun
sequencing—and rapid point-of-care tests (LAMP, CRISPR-Cas). We should also not
forget the impact of digitalisation and artificial intelligence, which will
result in digital tools predicting the likelihood of a pathogen being involved
in a given case based on data such as previous laboratory results,
circumstantial evidence and national surveillance data (Lowie et al., 2021). In
the EU DECIDE project, a cattle barometer was developed: a dashboard in which
laboratories share test results, visualising spatiotemporal trends in
respiratory pathogens (https://decideproject.eu/barometer). This open
access information can be used by veterinarians and farmers for shared
decision-making regarding vaccination and increased biosecurity measures, and
by pharmaceutical compagnies to highlight the prevalence of the pathogens they
have products for.
Simultaneously with the positive
developments in veterinary laboratories, there is a clear trend towards more
testing within veterinary practices themselves (on-practice or in-clinic
testing), as well as a desire for cow-side (point-of-care) testing. On-practice
bacterial culture is commercially available for mastitis pathogens. It could
also be used for respiratory pathogens but currently still faces hurdles such
as more difficult phenotypic identification, the need for specific media (Mycoplasma
spp.) and specific incubation conditions (CO₂ for Histophilus somni). In
addition to culturing, the use of on-practice LAMP testing for mastitis
pathogens has markedly increased in recent years, and test panels are becoming
available for respiratory pathogens as well. LAMP (loop-mediated isothermal
amplification) has the advantage that it can be performed at a single constant
temperature, can use multiple primers and can provide a test result within an
hour. Commercial devices are available and can handle either a single sample or
up to five samples in a single run. In principle, the equipment can even be
installed in a vehicle to provide on-farm services.
Published data on LAMP for BRD pathogens remain limited but encouraging. For M. bovis, a LAMP assay performed directly on 135 nasal swabs, without pre-culture, showed 97.2% sensitivity and 90.9% specificity, with a result within 60 minutes (Higa et al., 2016). For P. multocida, M. haemolytica and H. somni, a colorimetric LAMP assay was run on-farm on crude nasal swabs, without nucleic acid extraction, with a naked-eye readout within one hour; concordance with PCR, however, ranged from 60 to 100% depending on the pathogen, in a very small number of animals (n = 5) (Pascual-Garrigos et al., 2021). Extraction-free LAMP assays have also been developed for five respiratory viruses (BRSV, BPIV-3, BHV-1, BVDV-1 and bovine adenovirus 3), with an analytical sensitivity of 73–100% (Davidson et al., 2026). The strengths of LAMP therefore lie in its speed, tolerance to inhibitors, ability to work on minimally processed samples and simple equipment, enabling a result in practice, or even on-farm, during the visit. Pooled testing has proven valuable for other molecular methods (Bokma et al., 2021); for LAMP, pooling is currently limited to three samples and published data evaluating performance on pooled samples are still lacking. As for any new test, independent clinical validation, particularly on nBAL samples and under field conditions, remains necessary.[1]
Diagnostics can be costly; hence,
one of the million-dollar questions for BRD is: what is the return on
investment (ROI) of diagnostics? We need to differentiate between the
likelihood that a sample–test combination will result in detection of the
pathogen and what can actually be done with the information derived from the
test in terms of control and preventive actions. Many factors affect the
likelihood of detecting the pathogen. Of these, the veterinarian can influence
appropriate animal selection, sampling technique, storage and transport, and
selection of the laboratory performing the test. The veterinarian therefore
holds a crucial position in ensuring ROI. Which animals to sample and which
test to use is a frequently asked question to which my answer is: ‘It depends.’
There are sufficient indications for using each of the tests listed in table 1
in different scenarios, depending on whether the aim is a purchase examination,
a culling decision, pathogen identification during an outbreak, etc. For the latter
purpose, to ensure an acceptable likelihood of detecting the pathogens
involved, the author recommends sampling five animals, which is statistically
based on the detection-of-disease approach (Pardon and Buczinski, 2020).
Selection criteria include the presence of lung consolidation and no
antimicrobial or anti-inflammatory therapy in the previous 14 days. The
presence of cough and/or fever is an additional criterion when available.
Timing of sampling matters as well: after experimental BRSV infection, viral
RNA remained detectable in nasal swabs for up to four weeks, whereas infectious
virus was only isolated during the first two weeks (Klem et al., 2019).
Sampling in the acute stage, which lung ultrasound now helps to identify
earlier, therefore increases the likelihood of identifying the primary
pathogen. In case of treatment failure, bacterial culture with antimicrobial
susceptibility testing remains the most relevant tool to guide subsequent
treatment. Beyond this, current evidence does not yet allow an optimal timing
to be defined for each technology. To obtain a complete picture of the primary
and opportunistic pathogens involved, we recommend to collect five nBAL
samples. On each individual sample, culture for Pasteurellaceae and
other opportunists is performed; M. bovis culture or rapid MALDI-TOF on
the individual samples is optional. On a pooled sample from the five animals,
either multiplex PCR, or nanopore sequencing or LAMP (limited to three samples)
is performed to detect viruses and M. bovis. This approach helps to
identify the primary pathogens involved and to better understand whether
opportunistic superinfection has already occurred and whether a given bacterial
species is dominant. If the interest lies in demonstrating that M. bovis
is involved, for example as a condition for using metaphylaxis, PCR or rapid
MALDI-TOF on a pool of five DNS samples may be the most cost-effective and
animal-friendly approach. Context matters.
Returning to ROI and to what the
potential value is of diagnostics. Diagnostics can aid in antimicrobial
stewardship and through a pathogen-oriented approach may aid in focusing farm
resources (financial and labor) to critical control points related to these
specific pathogens or investing in the right vaccine. ROI should also not be
limited to the farmer, as on-practice or cow-side testing may offer an
interesting business model, in a food-animal practice with a shift away from
medication sales towards test and consultancy honorarium. Anyway, both
veterinarians and their clients need reliable, rapid and especially affordable
diagnostics.
Finally, we need to realise that even the best diagnostic test just provides data. It is up to the veterinarian to transform these data into actionable information and, ultimately, effective interventions, hereby maximising the ROI of diagnostic tests. This requires education, hands-on training, certification and continued support.
Figure 1. Non-endoscopic bronchoalveolar lavage sampling in a calf with pneumonia by means of the custom-made UGent catheter (Teflon, 4mm outer, 2mm inner diameter).
Table 1. Overview of advantages and limitations of available diagnostic test for respiratory pathogens in cattle |
|||
|
Method |
Pros |
Cons |
Likely future evolution |
|
Bacterial culture (agar + biochemical ID or MALDI-TOF) |
-Gold standard for viable, culturable isolates -Antimicrobial susceptibility testing possible -Inexpensive -Information on mixed infections |
-Slow (24-72h for antibiogram; > 6 days for Mycoplasma
culture) -Lower sensitivity -Labor intensive -Trained staff required -Some pathogens grow poorer (false negatives; eg. Histophilus
somni) -No pooling |
- Will remain important as reference method - Increasingly combined with molecular methods - Automation, e.g. with MALDI-TOF |
|
Rapid (direct) MALDI-TOF |
- Fast -Low cost -Good sensitivity (Se) and specificity (Sp) -Pooling possible |
-Expensive equipment (lab-based only) -No identification of viruses -High Se en Sp only for M. bovis -Lower accuracy in polymicrobial and mixed samples (for Pasteurellaceae) |
-Extension to other bacteria -Antimicrobial resistance testing -Improvement of diagnostic chain making identification and
susceptibility test result available within a working day |
|
PCR (conventional and multiplex) |
-Fast (hours-same day possible) -High sensitivity and specificity -Detect non-culturable bacteria -Test multiple pathogens (viruses and bacteria) in a
single run -Pooling possible |
- More expensive - Detects ‘dead DNA’ (interpretation issues) - Sensitive to inhibiters - No strain typing - Limited to predefined targets - Specialised equipment and trained staff needed - Often takes 3 days under real-live conditions |
- Expected to remain the most frequently used test - Can evolve to syndromic panels with digital PCR - Inclusion of antimicrobial resistance markers - Integration of quantitative results |
|
Next Generation Sequencing (NGS) (targeted (tNGS) or
metagenomic (mNGS) |
-Broad spectrum, without predefined panel -No live organisms required -Detects non-culturable pathogens -Enables resistance genome profiling -Mapping of co-infections -Microbiome studies -Strain typing -Very high specificity -Pooling possible |
-More expensive -More complex interpretation (trained staff and extensive
database) - Longer turnaround time possible -Lower Se compared to PCR possible -Only for pathogen identification in routine diagnostics
available -Antibiogram not yet available -Often takes more than a day (3 for M. bovis) |
-Further development in sub-products -Likely larger role in research -Beter pipelines in diagnostic laboratories -Development of microbiome tests -Integration with inflammatory profiles (host) |
|
LAMP |
-Very fast; often within the hour -Isothermal, can run on compact readers (lower cost) -High Se; tolerant of inhibitors -Simple workflow, on-practice possible by non-laboratory
staff |
-Limited to fixed panel -Risk of contamination -Also detects ‘dead DNA’ (interpretation) -External validation pending |
-Expected to expand further as on-practice or even
car/barn test -More multiplex LAMP systems -Inclusion of resistance genes |
Bokma, J., et al. (2020). "Rapid Identification of
Mycoplasma bovis Strains from Bovine Bronchoalveolar Lavage Fluid with
Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry
after Enrichment Procedure." Journal of Clinical Microbiology 58(6).
Bokma, J., et al. (2021). "Evaluation of nanopore
sequencing as a diagnostic tool for the rapid identification of Mycoplasma
bovis from individual and pooled respiratory tract samples." Journal
of Clinical Microbiology: JCM0111021.
Buczinski, S., D. Achard and E. Timsit (2021).
"Effects of calfhood respiratory disease on health and performance of
dairy cattle: A systematic review and meta-analysis." Journal of Dairy
Science 104(7): 8214–8227.
Buczinski, S., et al. (2026). "Lung ultrasonography
used as a diagnostic test for respiratory disease diagnosis in calves:
Systematic review and meta-analysis using a Bayesian latent-class modeling
approach." Journal of Dairy Science 109(8): 8748–8765.
Davidson, J. L., et al. (2026). "Detection of five
viruses commonly implicated with bovine respiratory disease using loop-mediated
isothermal amplification." Veterinary Quarterly 46(1).
doi:10.1080/01652176.2025.2607418.
Dubrovsky, S. A., et al. (2020). "Preweaning cost of
bovine respiratory disease (BRD) and cost-benefit of implementation of
preventative measures in calves on California dairies: The BRD 10K study."
Journal of Dairy Science 103(2): 1583–1597.
Dunn, T. R., et al. (2018). "The effect of lung
consolidation, as determined by ultrasonography, on first-lactation milk
production in Holstein dairy calves." Journal of Dairy Science 101(6):
5404–5410.
Higa, Y., et al. (2016). "An improved loop-mediated
isothermal amplification assay for the detection of Mycoplasma bovis."
Journal of Veterinary Medical Science 78(8): 1343–1346.
Jourquin, S., et al. (2022). "Randomized field trial
comparing the efficacy of florfenicol and oxytetracycline in a natural outbreak
of calf pneumonia using lung reaeration as a cure criterion." Journal
of Veterinary Internal Medicine 36(2): 820–828.
Jourquin, S., et al. (2024). "Non-inferiority trial in
veal calves on the efficacy of oxytetracycline and florfenicol treatment for
pneumonia guided by quick thoracic ultrasound." Journal of Dairy
Science 108(2); 1896-1916.
Jourquin, S., et al. (2025). "Development of a
classification system for lung ultrasonographic findings in calves based on the
association with cure and production outcomes." Journal of Dairy
Science 108(7): 7452–7471.
Klem, T. B., et al. (2019). "Bovine respiratory
syncytial virus in experimentally exposed and rechallenged calves; viral
shedding related to clinical signs and the potential for transmission."
BMC Veterinary Research 15: 156.
Lowie, T., et al. (2021). "Decision tree analysis for
pathogen identification based on circumstantial factors in outbreaks of bovine
respiratory disease in calves." Preventive Veterinary Medicine 196:
105469
Lowie, T., et al. (2022). "Differences in the
association of cough and other clinical signs with ultrasonographic lung
consolidation in dairy, veal, and beef calves." Journal of Dairy
Science 105(7): 6111–6124.
Motus, K., et al. (2026). "Longitudinal dynamics and
recovery of lung ultrasonographic consolidations, association with growth in
dairy calves in herds with circulating bovine coronavirus and
Pasteurellaceae." Journal of Dairy Science 109(8):
8766–8783.
Pardon, B., et al. (2013). "Impact of respiratory
disease, diarrhea, otitis and arthritis on mortality and carcass traits in
white veal calves." BMC Veterinary Research 9: 79.
Pardon, B. and S. Buczinski (2020). "Bovine Respiratory Disease Diagnosis: What Progress Has Been Made in Infectious Diagnosis?" Vet Clin North Am Food Anim Pract 36(2): 425–444.
Pascual-Garrigos, A., et al. (2021). "On-farm
colorimetric detection of Pasteurella multocida, Mannheimia haemolytica, and
Histophilus somni in crude bovine nasal samples." Veterinary Research 52:
126.
Rouault, M., G. Foucras, F. Meurens, C. Toczé and S. Assié
(2024). "Association des agents pathogènes avec les lésions pulmonaires
échographiques des jeunes bovins en engraissement : place du coronavirus
bovin." Journées nationales des Groupements techniques vétérinaires
(JNGTV): 579–584.
Van Driessche, L., et al. (2017). "A Deep
Nasopharyngeal Swab Versus Nonendoscopic Bronchoalveolar Lavage for Isolation
of Bacterial Pathogens from Preweaned Calves With Respiratory Disease." Journal
of Veterinary Internal Medicine 31(3): 946–953.
Van Driessche, L., et al. (2018). "Rapid detection of
tetracycline resistance in bovine Pasteurella multocida isolates by
MALDI Biotyper antibiotic susceptibility test rapid assay (MBT-ASTRA)." Scientific
Reports 8 (1) 13599.
Van Driessche, L., et al. (2019). "Rapid identification of respiratory bacterial pathogens from bronchoalveolar lavage fluid in cattle by MALDI-TOF MS." Sci Rep 9(1): 18381.